Related Experiment Video
Updated: Feb 8, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis
Sharon M Moe1,2, Jin Long3, Tae-Hwi Linus Schwantes-An4
1Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Insights
Genetic variants in AGTR1 and ACE influence cardiovascular mortality in dialysis patients. The AGTR1 rs5186 C allele is linked to increased cardiovascular events and death in European and African ancestry groups.
Area of Science:
- Cardiovascular genetics
- Renal medicine
- Pharmacogenomics
Background:
- Cardiovascular mortality is high in dialysis patients.
- Ancestry differences in outcomes suggest genetic factors.
- Secondary hyperparathyroidism is common in hemodialysis patients.
Purpose of the Study:
- Investigate genetic associations with cardiovascular mortality in dialysis patients.
- Analyze single-nucleotide polymorphisms (SNPs) in AGTR1 and ACE genes.
- Conduct a meta-analysis across European and African ancestry groups.
Main Methods:
- DNA samples from the EVOLVE trial (cinacalcet vs. placebo) were analyzed.
- SNPs in angiotensin-converting enzyme receptor type I (AGTR1) and angiotensin-converting enzyme (ACE) genes were genotyped.
- Survival analyses were performed separately for European Ancestry (EA) and African Ancestry (AfAn) populations, followed by meta-analysis.
Main Results:
- Meta-analysis revealed significant association of AGTR1 rs5186 with increased rates (25-34%) of the primary composite endpoint, all-cause mortality, cardiovascular mortality, and heart failure (P < 0.001).
- Three ACE SNPs were linked to reduced sudden cardiac death (SCD) rates in EA.
- One ACE SNP (rs4318) was associated with lower SCD rates in AfAn.
Conclusions:
- The AGTR1 rs5186 C allele is associated with higher mortality and major cardiovascular events in EA and AfAn patients with end-stage kidney disease.
- ACE gene variants show associations with sudden cardiac death in dialysis patients.
Background:
Cardiovascular mortality in patients receiving dialysis remains unacceptably high, with unexplained ancestry differences suggesting a genetic component.
Methods:
We analyzed DNA samples from 37% of subjects enrolled in the EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events (EVOLVE) trial, a randomized trial conducted in patients receiving hemodialysis with secondary hyperparathyroidism, comparing cinacalcet to placebo on a background of usual care. DNA was analyzed for single-nucleotide polymorphisms (SNPs) in the genes encoding the angiotensin-converting enzyme receptor type I (AGTR1) and angiotensin-converting enzyme (ACE). Survival analyses were conducted separately in European Ancestry (EA) and African Ancestry (AfAn) due to known differences in cardiovascular events, minor alleles for the same variant and the frequency of minor alleles. Our primary determination was a meta-analysis across both races.
Results:
Meta-analysis showed significant associations between rs5186 in AGTR1 and increased rates by 25-34% for the primary endpoint (composite of death or nonfatal myocardial infarction, hospitalization for unstable angina, heart failure or peripheral vascular event), all-cause mortality, cardiovascular mortality and heart failure; all P < 0.001. Three correlated SNPs in ACE were associated with lower rates of sudden cardiac death (SCD) in EA samples. One ACE SNP, rs4318, only found in the AfAn samples, was associated with a lower rate of SCD in the AfAn samples.
Conclusions:
The C allele in rs5186 in AGTR1 was associated with higher rates of death and major cardiovascular events in a meta-analysis of EA and AfAn patients with end-stage kidney disease. SNPs in ACE were associated with SCD.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Hemodialysis I: Introduction
What is Genetic Engineering?
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Genetics of Speciation

